You have 9 free searches left this month | for more free features.

Carcinoma, Squamous Cell

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Disease-free Survival of High-risk Head-neck Cutaneous Squamous

Active, not recruiting
  • Carcinoma, Squamous Cell
  • +5 more
  • Treatment
  • Maastricht, Netherlands
  • +1 more
Apr 26, 2023

Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

Not yet recruiting
  • Squamous Cell Carcinoma
    • San Francisco, California
      Power Life Sciences
    Jun 23, 2023

    Cutaneous Squamous Cell Carcinoma Trial (INCB099280)

    Not yet recruiting
    • Cutaneous Squamous Cell Carcinoma
    • (no location specified)
    May 24, 2023

    Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • no intervention
    • Wuhan, Hubei, China
      Renmin hosptial of Wuhan University
    Jul 29, 2023

    Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • PET/CT
    • Neck dissection
    • (no location specified)
    Jan 31, 2023

    Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
    • (no location specified)
    Mar 17, 2023

    Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])

    Not yet recruiting
    • Neoplasms
    • +2 more
    • Nivolumab Injection [Opdivo]
    • (no location specified)
    Jul 19, 2023

    Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

    Not yet recruiting
    • Locally Advanced Head and Neck Squamous Cell Carcinoma
    • (no location specified)
    Mar 20, 2023

    Head and Neck Squamous Cell Carcinoma Trial (Carrilizumab, bevacizumab,capecitabine)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Carrilizumab, bevacizumab,capecitabine
    • (no location specified)
    Jul 20, 2023

    Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with

    Not yet recruiting
    • Advanced Esophageal Squamous Carcinoma With Oligometastases
    • simultaneous with radiotherapy
    • synchronous with radiotherapy
    • (no location specified)
    Nov 16, 2023

    Esophageal Squamous Cell Carcinoma Trial (Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin
    • (no location specified)
    Aug 17, 2023

    Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

    Recruiting
    • Esophageal Squamous Cell Carcinoma
      • Shijiazhuang, Hebei, China
        Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
      Oct 25, 2023

      Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

      Recruiting
      • Metastatic Esophageal Squamous Cell Carcinoma
      • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors´╝łSintilimab´╝ë
      • Qingdao, Shandong, China
      • +1 more
      Nov 13, 2023

      Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

      Not yet recruiting
      • Esophageal Squamous Cell Carcinoma
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Nov 30, 2023

      Oral Cancer, Oral Squamous Cell Carcinoma Trial in Fayoum (ELISA)

      Recruiting
      • Oral Cancer
      • Oral Squamous Cell Carcinoma
      • ELISA
      • Fayoum, Egypt
        Fayoum University
      Sep 8, 2023

      Salivary LINC00657 asDiagnostic Biomarker for Oral Squamous Cell

      Completed
      • Oral Squamous Cell Carcinoma
        • Fayoum, Egypt
          faculty of dentistry, Fayoum university
        Apr 19, 2023

        Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Carrilizumab with albumin-binding paclitaxel)

        Not yet recruiting
        • Squamous Cell Carcinoma of the Skin
        • Carrilizumab with albumin-binding paclitaxel
        • Zhengzhou, Henan, China
          Henan Cancer Hospital
        May 23, 2023

        Resectable Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy Trial (cadonilimab+chemo)

        Not yet recruiting
        • Resectable Esophageal Squamous Cell Carcinoma
        • Neoadjuvant Therapy
        • (no location specified)
        Apr 18, 2023

        Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma

        Recruiting
        • Head and Neck Squamous Cell Carcinoma
          • Hangzhou, Zhejiang, China
            Second Affiliated Hospital, School of Medicine, Zhejiang Univers
          Aug 22, 2023

          Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

          Recruiting
          • Esophageal Squamous Cell Carcinoma
          • Head and Neck Squamous Cell Carcinoma
          • Chengdu, Sichuan, China
            West China Hospital, Sichuan University
          Oct 25, 2023

          WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA

          Recruiting
          • Oral Cancer
          • +2 more
          • Biopsy Specimens Histopathology
          • Rawalpindi, Punjab, Pakistan
            Armed Forces Institute of Pathology
          Jun 22, 2023

          Advanced Lung Squamous Cell Carcinoma

          Not yet recruiting
          • Advanced Lung Squamous Cell Carcinoma
          • No treatment is included in this study
          • Changsha, Hunan, China
            Yongchang Zhang
          Aug 11, 2023

          Minimal Residual Disease, Esophageal Squamous Cell Carcinoma Trial in Guangzhou

          Not yet recruiting
          • Minimal Residual Disease
          • Esophageal Squamous Cell Carcinoma
            • Guangzhou, Guangdong, China
              Guangdong Provincial People's Hospital
            Jun 10, 2023

            Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

            Not yet recruiting
            • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
            • Guangzhou, Guangdong, China
              Sun Yat-sen University
            Oct 24, 2023

            Esophageal Squamous Cell Carcinoma Trial (XH-30002 capsule, Afatiinb tablet)

            Not yet recruiting
            • Esophageal Squamous Cell Carcinoma
            • XH-30002 capsule
            • Afatiinb tablet
            • (no location specified)
            Jun 25, 2023